SHPH Shuttle Pharmaceuticals Hol...

Nasdaq shuttlepharma.com


$ 3.55 $ -0.05 (-1.36 %)    

Friday, 17-Oct-2025 15:59:53 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 3.63
$ 3.69
$ 3.30 x 3
$ 3.96 x 1
$ 3.37 - $ 3.72
$ 3.00 - $ 56.25
79,252
na
3.89M
$ 5.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 09-04-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-21-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-25-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shuttle-pharma-executes-non-binding-loi-to-acquire-moleculeai-and-its-platform-for-10m-in-combination-of-cash-and-common-shares

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-announces-non-binding-loi-to-purchase-moleculeai-for-10m

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-q2-eps-329-up-from-2412-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over los...

 shuttle-pharmaceuticals-has-been-granted-us-patent-number-12357650-titled-methods-and-compositions-for-cancer-therapies-that-include-delivery-of-halogenated-thymidines-and-thymidine-phosphorlylase-inhibitors-in-combination-with-radiation

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12357650).pn

 shuttle-pharmaceuticals-announces-pricing-of-425m-private-placement-at-a-purchase-price-of-360-per-share

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharma-board-approves-proposed-reverse-stock-split-of-common-stock-at-ratio-of-25-for-1

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharma-announces-the-appointment-of-george-scorsis-as-the-chairman-of-the-board-of-directors

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION